Synapse - Find an Expert

1253 Results

Multicenter phase II trial of temsirolimus and bevacizumab in pancreatic neuroendocrine tumors

Journal Article

Hobday, T. J.; Qin, R.; Reidy-Lagunes, D.; Moore, M. J.; Strosberg, J.; Kaubisch, A.; Shah, M.; Kindler, H. L.; Lenz, H. J.; Chen, H.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Long-term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high-risk prostate cancer

Journal Article

Silberstein, J. L.; Poon, S. A.; Sjoberg, D. D.; Maschino, A. C.; Vickers, A. J.; Bernie, A.; Konety, B. R.; Kevin Kelly, W.; Eastham, J. A.
BJU International (2015)

Fulltext@MSK | Save

A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 mutation - An NRG Oncology/Gynecologic Oncology Group study

Journal Article

Coleman, R. L.; Sill, M. W.; Bell-Mcguinn, K.; Aghajanian, C.; Gray, H. J.; Tewari, K. S.; Rubin, S. C.; Rutherford, T. J.; Chan, J. K.; Chen, A.; more...
Gynecologic Oncology (2015)

Fulltext@MSK | Save

Incomplete cross-resistance between taxanes for advanced urothelial carcinoma: Implications for clinical practice and trial design

Journal Article

Sonpavde, G.; Pond, G. R.; Mullane, S.; Qu, A. Q.; di Lorenzo, G.; Federico, P.; Necchi, A.; Rosenberg, J. E.; Bellmunt, J.; Choueiri, T. K.
Clinical Genitourinary Cancer (2015)

Fulltext@MSK | Save

Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma

Journal Article

Herman, J. M.; Chang, D. T.; Goodman, K. A.; Dholakia, A. S.; Raman, S. P.; Hacker-Prietz, A.; Iacobuzio-Donahue, C. A.; Griffith, M. E.; Pawlik, T. M.; Pai, J. S.; more...
Cancer (2015)

Fulltext@MSK | Save

Ibrutinib in previously treated Waldenström's macroglobulinemia

Journal Article

Treon, S. P.; Tripsas, C. K.; Meid, K.; Warren, D.; Varma, G.; Green, R. ; Argyropoulos, K. V.; Yang, G.; Cao, Y.; Xu, L.; more...
New England Journal of Medicine (2015)

Fulltext@MSK | Save

Immunosuppressive therapy of LGL leukemia: Prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998)

Journal Article

Loughran, T. P.; Zickl, L.; Olson, T. L.; Wang, V.; Zhang, D.; Rajala, H. L. M.; Hasanali, Z.; Bennett, J. M.; Lazarus, H. M.; Litzow, M. R.; more...
Leukemia (2015)

Fulltext@MSK | Save

Efficacy and safety of MCNA in patients with nonmuscle invasive bladder cancer at high risk for recurrence and progression after failed treatment with bacillus Calmette-Guérin

Journal Article

Morales, A.; Herr, H.; Steinberg, G.; Given, R.; Cohen, Z.; Amrhein, J.; Kamat, A. M.
Journal of Urology (2015)

Fulltext@MSK | Save

Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia